Non-responders to hepatitis B vaccination: a review.
Hepatitis B virus (HBV) infection is a major public health issue throughout the world and vaccination of those at risk is the main method of containment. Of healthy vaccinees, 5-10% fail to mount an adequate antibody response. The antibody levels of an unknown further fraction of vaccinees fall considerably over time rendering them at a potential risk of infection. The scope of this article is to review the factors that might influence the immune response to HBV vaccination, to review the methods used to overcome the problem of poor response and to discuss what possible guidelines are available or needed in treating these vaccinees.
Kubba
A K
AK
Department of Occupational Medicine, Royal Marsden Hospital. ak.kubba@virgin.net
Taylor
P
P
Graneek
B
B
Strobel
S
S
D006509:Hepatitis B / Q000276:immunology* / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000276:immunology*; D017325:Hepatitis B Vaccines / Q000276:immunology*; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D017410:Practice Guidelines as Topic
D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines